FDA Investigator Zi Qiang Gu
Zi Qiang Gu has conducted inspections on 17 sites in 2 countries as of 24 May 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
17
Last Inspection Date:
24 May 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
China,
United States of America
FDA Investigators that have inspected at least one site in common with Zi Qiang Gu:
Alan L Truong,
Andrew A Hoopes,
Anthony R Bucks,
Ashley A Mutawakkil,
Azeezat M Lawal,
Brenda W Uratani, PhD,
Brett R Havranek,
Brittany D Terhar,
Brooke K Higgins,
Candice C Mandera,
Candice J Cortes,
Carl A Huffman, III,
Carl Lee,
Charles I Ann,
Charles M Edwards,
Chiang Syin, PhD,
Christine A Harman, PhD,
Christopher T Middendorf,
Cody D Rickman,
Damaris Y Hernandez,
Darren S Brown,
David A Oluwo,
David J Eide,
Djamila Harouaka,
Donald L Myers,
Dongping Dai, PhD,
Dr. Gang Wang, PhD,
Dr. Guang Gao, PhD,
Dr. Robert C Horan, MD,
Dr. S Nar Ali, PhD,
Edwin Melendez,
Emest F Bizjak,
Eric M Mueller, PharmD,
Eric M Padgett,
Farhana Khan,
Felix Maldonado,
Francis A Guidry,
Gale L Glinecki,
George Pyramides,
Guo Q Shen,
Gwyn G Dickinson,
Harry J Brewer,
Hector A Carrero,
Helen Y Saccone,
Heriberto Negron Rivera,
Ivis L Negron,
Jacqueline Mdiaz Albertini,
James I Giefer,
James W Leonette,
Jane L Chang,
Janet B Abt,
Jazmine N Still,
Jeffery A Hangartner,
John M Dietrick,
Johnny D Nwankwo,
Jose A Lopez,
Jose R Hernandez,
Joseph R Lambert,
Katherine Szestypalow,
Kelly K Nachtigal,
Ken L Bowers,
Kenneth Nieves,
Kevin D Kallander,
Kevin P Foley,
Kham Phommachanh,
Kim Lthomas Cruse,
Larry K Austin,
Latoya S Oliver Powell,
Lewis K Antwi,
Margaret A Smithers,
Marie F Morin,
Marijo B Kambere, PhD,
Matthew B Casale,
Matthew J Johnson,
Matthew M Schuckmann,
Matthew R Sleeter,
Michele L Obert,
Michele Perry Williams,
Miguel A Martinez Perez,
Monica M Mcclure,
Nancy G Schmidt,
Neal L Adams,
Nebil A Oumer,
Nelson N Ayangho,
Omotunde O Osunsanmi,
Paul L Bellamy,
Paula A Trost,
Peter E Baker,
Qin Xu,
Rachel C Harrington,
Ralph H Vocque,
Regina T Brown,
Richard L Rutherford,
Rita K Kabaso,
Robert J Ham,
Rose Xu,
Sarah E Rhoades,
Scott A Golladay,
Shafiq S Ahadi,
Shirley H Isbill,
Shirley J Berryman,
Sidney B Priesmeyer,
Simone E Pitts,
Sony Mathews,
Stacey A Priest,
Steven D Kehoe,
Steven P Donald,
Susan M Jackson,
Susan W Ting,
Susanna E Ford,
Suzanne M Healy,
Suzanne M Muchene,
Syed N Ali,
Syeda N Mahazabin,
Tara L Breckenridge,
Tara L Greene,
Tracey L Harris,
Walsworth,
Xiandong Meng,
Yan Qin,
Yvette I Henry,
Yvette I Johnson
Zi Qiang Gu's Documents
Publish Date | Document Type | Title |
---|---|---|
June, 2002 | FDA 483 | Wuhan Pharmaceutical Factory - Form 483, 2002-06-27 |
February, 2010 | FDA 483 | Chempacific Corporation - Form 483, 2010-03-19 |
January, 2007 | FDA 483 | Scientific Laboratories, Inc. - Form 483, 2007-01-29 |
February, 2008 | FDA 483 | Changzhou SPL Company, Ltd. - Form 483, 2008-02-26 |
February, 2003 | EIR | Hospira, Inc. - EIR, 2003-02-27 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more